What is Acadia Healthcar's earnings per share (EPS)?

Acadia Healthcar (ACHC) reported diluted earnings per share of -$12.16 for fiscal year 2025. This represents a -537.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Acadia Healthcar Financials

ACHC

Trailing 12 months to March 31, 2026

Revenue $3.4B +6.8% YoY

Net Income -$1.1B -690.1% YoY

EPS (Diluted) -$12.20 -698.0% YoY

Free Cash Flow -$291.8M -12.2% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Apr 30, 2026 Currency USD FYE December

Acadia Healthcar (ACHC) reported $3.4B in revenue over the twelve months to Mar 31, 2026, up 6.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ACHC FY2025 2026-08-29

Steady revenue scale is being overshadowed by balance-sheet restructuring, heavier debt, and reinvestment that keeps free cash flow negative.

Revenue rose 5.0% in FY2025, yet net margin was -33.3%; earnings deterioration therefore came from costs, charges, or financing effects rather than shrinking sales alone. Goodwill fell by $969M alongside a -$1.1B net loss, a combination consistent with a balance-sheet event rather than a simple volume slowdown.

Operating cash flow remained positive at $132M, but capital expenditures reached $572M. That reinvestment gap left free cash flow at -$440M, so FY2024 accounting profitability did not translate into cash available after investment.

Debt-to-equity rose from 0.6x in FY2024 to 1.3x in FY2025 as equity fell. The current ratio improved to 1.6x, but that short-term improvement sits beside a more debt-dependent capital structure.

Financial Health Signals

Financial Health Score 26/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Acadia Healthcar's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Acadia Healthcar, and counted as zero in the overall score.

Growth

Acadia Healthcar's revenue grew 5.0% year-over-year to $3.3B, a solid pace of expansion. This earns a growth score of 55/100.

Leverage

Acadia Healthcar has a moderate D/E ratio of 1.27. This balance of debt and equity financing earns a leverage score of 41/100.

Liquidity

Acadia Healthcar's current ratio of 1.55 indicates adequate short-term liquidity, earning a score of 42/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Acadia Healthcar generated $131.9M in operating cash flow, capex of $571.8M consumed most of it, leaving -$439.9M in free cash flow. This results in a low score of 15/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Not available for Acadia Healthcar, and counted as zero in the overall score.

Piotroski F-Score Partial

5/8

Acadia Healthcar passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

N/A

Acadia Healthcar reported a net loss of $1.1B while generating $131.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.3B

YoY+5.0%

5Y CAGR+9.7%

Acadia Healthcar generated $3.3B in revenue in fiscal year 2025. This represents an increase of 5.0% from the prior year.

Net Income

-$1.1B

YoY-531.4%

Acadia Healthcar reported -$1.1B in net income in fiscal year 2025. This represents a decrease of 531.4% from the prior year.

EPS (Diluted)

-$12.16

YoY-537.4%

Acadia Healthcar earned -$12.16 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 537.4% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

-$439.9M

YoY+21.5%

Acadia Healthcar recorded an outflow of $439.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 21.5% from the prior year.

Cash & Debt

$133.2M

YoY+74.6%

5Y CAGR-18.9%

10Y CAGR+28.1%

Acadia Healthcar held $133.2M in cash against $2.5B in long-term debt as of fiscal year 2025.

Shares Outstanding

92M

YoY-0.8%

5Y CAGR+0.7%

10Y CAGR+0.6%

Acadia Healthcar had 92M shares outstanding in fiscal year 2025. This represents a decrease of 0.8% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Net Margin

-33.3%

YoY-41.4pp

5Y CAGR-1.1pp

Acadia Healthcar's net profit margin was -33.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 41.4 percentage points from the prior year.

Return on Equity

-56.6%

YoY-64.9pp

5Y CAGR-21.2pp

10Y CAGR-63.3pp

Acadia Healthcar's ROE was -56.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 64.9 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks

$50.0M

Acadia Healthcar spent $50.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$571.8M

YoY-17.2%

5Y CAGR+20.5%

10Y CAGR+7.6%

Acadia Healthcar invested $571.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.2% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

ACHC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ACHC quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$3.4B	$3.3B+5.0%	$3.2B+7.7%	$2.9B+12.2%	$2.6B+12.8%	$2.3B+10.7%	$2.1B+4.1%	$2.0B+5.4%	$1.9B-32.8%	$2.8B+0.9%	$2.8B	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$199.4M	$177.6M+13.3%	$156.8M+2.3%	$153.3M+23.3%	$124.3M+14.9%	$108.2M+10.6%	$97.8M+8.2%	$90.4M+4.4%	$86.6M+13.4%	$76.4M-12.0%	$86.8M+27.1%	$68.3M+85.1%	$36.9M+27.2%	$29.0M+34.3%	$21.6M+64.9%	$13.1M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$585.9M-1.3%	$593.6M-1.8%	$604.4M-0.7%	$608.6M+50.3%	$404.8M+87.9%	$215.5M+48.3%	$145.3M+79.5%	$81.0M	N/A
Interest Expense	-$148.0M	-$138.9M-19.3%	-$116.4M-41.7%	-$82.1M-17.7%	-$69.8M+9.4%	-$77.0M+51.3%	-$158.1M+15.6%	-$187.3M-1.5%	-$184.5M-4.8%	-$176.0M+2.9%	-$181.3M-69.9%	-$106.7M-121.4%	-$48.2M-29.5%	-$37.3M-225.1%	$29.8M+223.9%	$9.2M
Income Tax	$28.1M	$26.0M-66.4%	$77.4M+898.0%	-$9.7M-110.3%	$94.1M+39.3%	$67.6M+66.4%	$40.6M+61.9%	$25.1M+153.2%	$9.9M-73.4%	$37.2M+29.3%	$28.8M-46.1%	$53.4M+24.4%	$42.9M+65.2%	$26.0M+110.8%	$12.3M+333.8%	-$5.3M
Net Income	-$1.1B	-$1.1B-531.4%	$255.6M+1279.7%	-$21.7M-107.9%	$273.1M+43.3%	$190.6M+128.4%	-$672.1M-717.1%	$108.9M+162.0%	-$175.8M-187.9%	$199.8M+3153.1%	$6.1M-94.5%	$112.6M+35.5%	$83.0M+95.0%	$42.6M+108.7%	$20.4M+158.5%	-$34.9M
EPS (Diluted)	-$12.20	-$12.16-537.4%	$2.78+1258.3%	-$0.24-108.1%	$2.98+41.9%	$2.10+127.7%	-$7.59-712.1%	$1.24+161.7%	-$2.01-187.4%	$2.30+3185.7%	$0.07-95.7%	$1.64+9.3%	$1.50+76.5%	$0.85+60.4%	$0.53	-$1.86

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$828.8M+0.9%	$821.5M-3.5%	$851.6M-2.0%	$869.2M+12.8%	$770.5M-0.5%	$774.2M-5.1%	$815.6M+2.5%	$796.0M
SG&A Expenses	$467.0M+139.5%	-$1.2B-355.8%	$462.2M+2.2%	$452.4M+1.6%	$445.3M+140.2%	-$1.1B-358.9%	$428.1M+2.0%	$419.8M
Interest Expense	-$38.3M-1.1%	-$37.9M-3.6%	-$36.6M-4.2%	-$35.1M-20.4%	-$29.2M+3.0%	-$30.1M-0.5%	-$29.9M-2.6%	-$29.2M
Income Tax	$6.5M-17.1%	$7.8M+370.2%	$1.7M-86.2%	$12.1M+174.0%	$4.4M-1.7%	$4.5M-83.5%	$27.2M+6.1%	$25.6M
Net Income	$4.1M+100.3%	-$1.2B-3348.7%	$36.2M+20.3%	$30.1M+259.8%	$8.4M-74.3%	$32.6M-52.1%	$68.1M-13.2%	$78.5M
EPS (Diluted)	$0.05+100.4%	-$12.98-3345.0%	$0.40+21.2%	$0.33+266.7%	$0.09-75.0%	$0.36-51.4%	$0.74-12.9%	$0.85

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income.

ACHC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ACHC quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$5.5B-7.2%	$6.0B+11.2%	$5.4B+7.4%	$5.0B+4.6%	$4.8B-26.6%	$6.5B-5.5%	$6.9B+11.4%	$6.2B-3.9%	$6.4B+6.6%	$6.0B+40.8%	$4.3B+93.9%	$2.2B+80.2%	$1.2B+24.5%	$983.4M+138.1%	$413.0M
Current Assets	$814.1M+41.0%	$577.5M-3.1%	$596.0M+17.8%	$506.1M+2.2%	$495.0M-80.4%	$2.5B+365.4%	$542.2M+20.4%	$450.4M-4.5%	$471.6M+10.2%	$427.9M+45.2%	$294.7M+7.5%	$274.1M+88.9%	$145.1M+2.9%	$141.0M+25.2%	$112.6M
Cash & Equivalents	$133.2M+74.6%	$76.3M-23.8%	$100.1M+2.5%	$97.6M-27.0%	$133.8M-64.7%	$378.7M+280.5%	$99.5M+97.1%	$50.5M-24.9%	$67.3M+17.9%	$57.1M+408.8%	$11.2M-88.1%	$94.0M+1958.2%	$4.6M-90.8%	$49.4M-19.2%	$61.1M
Inventory	$5.7M+0.6%	$5.7M+6.7%	$5.3M+4.2%	$5.1M+6.3%	$4.8M-1.3%	$4.9M+19.0%	$4.1M-19.4%	$5.1M+5.6%	$4.8M+3.3%	$4.6M-1.0%	$4.7M+44.1%	$3.2M	N/A	N/A	N/A
Accounts Receivable	$440.6M+20.6%	$365.3M+1.1%	$361.5M+12.1%	$322.4M+14.6%	$281.3M+2.8%	$273.6M-5.3%	$288.9M-9.2%	$318.1M+7.1%	$296.9M+12.8%	$263.3M+21.6%	$216.6M+83.0%	$118.4M+23.5%	$95.9M+50.1%	$63.9M+81.8%	$35.1M
Goodwill	$1.3B-42.8%	$2.3B+1.7%	$2.2B+0.1%	$2.2B+1.0%	$2.2B+4.5%	$2.1B+1.0%	$2.1B+2.0%	$2.0B-25.7%	$2.8B+2.6%	$2.7B+26.0%	$2.1B+165.0%	$803.0M+21.4%	$661.5M+18.7%	$557.4M+198.4%	$186.8M
Total Liabilities	$3.4B+22.4%	$2.8B+11.9%	$2.5B+18.4%	$2.1B-4.5%	$2.2B-51.9%	$4.5B+4.7%	$4.3B+13.9%	$3.8B-0.5%	$3.8B-0.3%	$3.8B+48.3%	$2.6B+95.2%	$1.3B+78.2%	$743.9M+35.1%	$550.9M+74.0%	$316.6M
Current Liabilities	$525.2M-9.1%	$577.9M-34.8%	$885.8M+128.1%	$388.3M-4.1%	$404.9M-69.1%	$1.3B+182.2%	$463.6M+11.3%	$416.4M+10.3%	$377.4M+10.1%	$342.9M+18.1%	$290.2M+74.9%	$165.9M+44.7%	$114.7M+59.6%	$71.9M+76.7%	$40.7M
Long-Term Debt	$2.5B+31.5%	$1.9B+40.0%	$1.3B-1.6%	$1.4B-7.7%	$1.5B-50.2%	$3.0B-4.4%	$3.1B-1.7%	$3.2B-1.4%	$3.2B-1.5%	$3.3B+48.2%	$2.2B+108.6%	$1.1B+74.9%	$601.9M+29.3%	$465.6M+72.0%	$270.7M
Total Equity	$1.9B-36.6%	$3.1B+10.5%	$2.8B-1.1%	$2.8B+11.7%	$2.5B+32.5%	$1.9B-24.2%	$2.5B+7.4%	$2.3B-9.3%	$2.6B+18.7%	$2.2B+28.8%	$1.7B+91.0%	$881.0M+83.3%	$480.7M+11.1%	$432.6M+348.9%	$96.4M
Retained Earnings	-$765.8M-297.7%	$387.3M+194.1%	$131.7M-14.1%	$153.4M+228.1%	-$119.8M+61.4%	-$310.4M-185.8%	$361.7M+43.1%	$252.8M-41.0%	$428.6M+94.7%	$220.1M+2.9%	$214.0M+111.0%	$101.4M+451.3%	$18.4M+176.1%	-$24.2M+45.8%	-$44.6M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$5.5B+0.3%	$5.5B-13.8%	$6.4B+1.7%	$6.3B+2.6%	$6.1B+3.2%	$6.0B+1.5%	$5.9B+3.4%	$5.7B
Current Assets	$837.2M+2.8%	$814.1M+8.8%	$748.0M+8.2%	$691.6M+8.2%	$639.0M+10.6%	$577.5M-11.4%	$652.1M+1.1%	$645.2M
Cash & Equivalents	$158.5M+18.9%	$133.2M+12.3%	$118.7M-9.7%	$131.4M+44.0%	$91.2M+19.6%	$76.3M-7.1%	$82.1M+6.5%	$77.2M
Inventory	$5.9M+4.3%	$5.7M-9.0%	$6.2M+7.4%	$5.8M+1.9%	$5.7M+1.0%	$5.7M+2.5%	$5.5M-7.9%	$6.0M
Accounts Receivable	$471.8M+7.1%	$440.6M+2.3%	$430.8M+5.5%	$408.5M+3.0%	$396.6M+8.6%	$365.3M-4.8%	$383.9M-1.4%	$389.4M
Goodwill	$1.3B+0.4%	$1.3B-43.3%	$2.3B+0.4%	$2.3B0.0%	$2.3B+0.5%	$2.3B0.0%	$2.3B+0.2%	$2.3B
Total Liabilities	$3.4B-0.3%	$3.4B+8.5%	$3.1B+1.2%	$3.1B+3.7%	$3.0B+7.5%	$2.8B+1.5%	$2.7B+4.2%	$2.6B
Current Liabilities	$489.4M-6.8%	$525.2M+1.4%	$517.9M-1.1%	$523.7M+10.6%	$473.4M-18.1%	$577.9M-5.2%	$609.5M+11.5%	$546.5M
Long-Term Debt	$2.5B+0.9%	$2.5B+8.2%	$2.3B+1.7%	$2.2B+2.9%	$2.2B+16.2%	$1.9B+4.2%	$1.8B+1.7%	$1.8B
Total Equity	$2.0B+0.5%	$1.9B-37.5%	$3.1B+1.4%	$3.1B+1.2%	$3.0B-1.0%	$3.1B+1.4%	$3.0B+2.7%	$3.0B
Retained Earnings	-$761.7M+0.5%	-$765.8M-286.0%	$411.7M+9.7%	$375.4M+7.7%	$348.5M-10.0%	$387.3M+9.2%	$354.7M+23.8%	$286.6M

ACHC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ACHC quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$182.0M	$131.9M+1.7%	$129.7M-71.9%	$462.3M+21.5%	$380.6M+1.6%	$374.5M-43.2%	$658.8M+97.9%	$332.9M-19.6%	$414.1M+3.6%	$399.6M+10.5%	$361.5M+50.4%	$240.4M+108.5%	$115.3M+75.8%	$65.6M+93.4%	$33.9M+264.0%	-$20.7M
Capital Expenditures	$473.7M	$571.8M-17.2%	$690.4M+62.8%	$424.1M+43.2%	$296.1M+21.0%	$244.8M+8.8%	$225.0M-3.3%	$232.7M-8.1%	$253.2M-7.7%	$274.2M-10.8%	$307.5M+11.4%	$276.0M+143.8%	$113.2M+64.3%	$68.9M+149.8%	$27.6M+188.7%	$9.6M
Free Cash Flow	-$291.8M	-$439.9M+21.5%	-$560.7M-1567.5%	$38.2M-54.7%	$84.4M-34.9%	$129.7M-70.1%	$433.8M+332.9%	$100.2M-37.7%	$160.9M+28.3%	$125.4M+132.2%	$54.0M+251.5%	-$35.6M-1845.5%	$2.0M+160.4%	-$3.4M-153.6%	$6.3M+120.9%	-$30.2M
Investing Cash Flow	-$433.2M	-$556.2M+24.5%	-$736.5M-85.4%	-$397.2M-29.9%	-$305.8M-130.2%	$1.0B+459.5%	-$281.8M-40.1%	-$201.1M+44.3%	-$361.0M-7.3%	-$336.5M+49.0%	-$660.4M	N/A	-$860.8M-254.3%	-$243.0M+53.7%	-$524.6M-132.6%	-$225.6M
Financing Cash Flow	$318.5M	$481.3M-17.5%	$583.0M+1029.9%	-$62.7M+43.5%	-$110.9M+93.2%	-$1.6B-3077.8%	-$51.5M+16.4%	-$61.6M+8.5%	-$67.3M-12.1%	-$60.1M-116.7%	$358.8M	N/A	$838.0M+532.0%	$132.6M-72.3%	$479.0M+60.3%	$298.7M
Share Buybacks	N/A	$50.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$61.5M+171.3%	-$86.3M-217.9%	$73.2M-45.2%	$133.5M+1063.2%	$11.5M-90.2%	$116.7M-28.5%	$163.1M-4.7%	$171.1M
Capital Expenditures	$76.6M-17.8%	$93.2M-31.6%	$136.2M-18.8%	$167.7M-3.9%	$174.6M-14.2%	$203.5M+7.0%	$190.2M+23.3%	$154.2M
Free Cash Flow	-$15.0M+91.6%	-$179.5M-184.8%	-$63.0M-84.1%	-$34.2M+79.0%	-$163.2M-88.0%	-$86.8M-220.2%	-$27.1M-260.4%	$16.9M
Investing Cash Flow	-$60.2M+34.9%	-$92.4M+28.8%	-$129.8M+13.9%	-$150.8M+17.7%	-$183.2M+9.9%	-$203.3M-5.3%	-$193.1M-24.2%	-$155.5M
Financing Cash Flow	$23.9M-87.6%	$193.3M+341.1%	$43.8M-23.7%	$57.5M-69.2%	$186.7M+131.1%	$80.8M+131.5%	$34.9M+320.9%	-$15.8M
Share Buybacks	N/A	$0	$0-100.0%	$3.2M-93.3%	$46.9M	N/A	N/A	N/A

Not reported in any period shown, so not listed: Dividends Paid.

ACHC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ACHC quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	29.2%-2.0pp	31.2%+9.8pp	21.3%-0.3pp	21.6%	N/A	N/A	N/A	N/A	N/A
Net Margin	-33.3%-41.4pp	8.1%+8.8pp	-0.7%-11.2pp	10.5%+2.2pp	8.2%+40.4pp	-32.2%-37.6pp	5.4%+14.6pp	-9.2%-16.3pp	7.0%+6.8pp	0.2%	N/A	N/A	N/A	N/A	N/A
Return on Equity	-56.6%-64.9pp	8.3%+9.1pp	-0.8%-10.5pp	9.7%+2.1pp	7.6%+43.0pp	-35.4%-39.7pp	4.3%+11.9pp	-7.5%-15.3pp	7.8%+7.5pp	0.3%-6.4pp	6.7%-2.7pp	9.4%+0.6pp	8.9%+4.1pp	4.7%+40.9pp	-36.2%
Return on Assets	-20.0%-24.2pp	4.3%+4.7pp	-0.4%-5.9pp	5.5%+1.5pp	4.0%+14.3pp	-10.3%-11.9pp	1.6%+4.4pp	-2.9%-6.0pp	3.1%+3.0pp	0.1%-2.5pp	2.6%-1.1pp	3.8%+0.3pp	3.5%+1.4pp	2.1%+10.5pp	-8.5%
Current Ratio	1.55+0.6x	1.00+0.3x	0.67-0.6x	1.30+0.1x	1.22-0.7x	1.93+0.8x	1.17+0.1x	1.08-0.2x	1.250.0x	1.25+0.2x	1.02-0.6x	1.65+0.4x	1.27-0.7x	1.96-0.8x	2.77
Debt-to-Equity	1.27+0.7x	0.61+0.1x	0.480.0x	0.49-0.1x	0.59-1.0x	1.56+0.3x	1.24-0.1x	1.35+0.1x	1.25-0.3x	1.50+0.2x	1.30+0.1x	1.19-0.1x	1.25+0.2x	1.08-1.7x	2.81
FCF Margin	-13.3%+4.5pp	-17.8%-19.1pp	1.3%-1.9pp	3.2%-2.4pp	5.6%-15.2pp	20.8%+15.8pp	5.0%-3.5pp	8.5%+4.0pp	4.4%+2.5pp	1.9%	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Net Margin	0.5%	-143.3%	4.3%+0.8pp	3.5%+2.4pp	1.1%-3.1pp	4.2%-4.1pp	8.3%-1.5pp	9.9%
Return on Equity	0.2%+60.6pp	-60.4%-61.6pp	1.2%+0.2pp	1.0%+0.7pp	0.3%-0.8pp	1.1%-1.2pp	2.3%-0.4pp	2.7%
Return on Assets	0.1%+21.4pp	-21.3%-21.9pp	0.6%+0.1pp	0.5%+0.3pp	0.1%-0.4pp	0.5%-0.6pp	1.2%-0.2pp	1.4%
Current Ratio	1.71+0.2x	1.55+0.1x	1.44+0.1x	1.320.0x	1.35+0.4x	1.00-0.1x	1.07-0.1x	1.18
Debt-to-Equity	1.270.0x	1.27+0.5x	0.730.0x	0.730.0x	0.72+0.1x	0.610.0x	0.600.0x	0.60
FCF Margin	-1.8%+20.0pp	-21.9%-14.5pp	-7.4%-3.5pp	-3.9%+17.2pp	-21.2%-10.0pp	-11.2%-7.9pp	-3.3%-5.4pp	2.1%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Lifestance Health Group, Inc. LFST

$4.7B

Addus Homecare Corp ADUS

$2.2B

Amedisys Inc AMED

$3.3B

Surgery Partners Inc SGRY

$1.8B

CONCENTRA GROUP HOLDINGS PAREN CON

$4.4B

Where Acadia Healthcar Ranks

Frequently Asked Questions

What is Acadia Healthcar's annual revenue?

Acadia Healthcar (ACHC) reported $3.3B in total revenue for fiscal year 2025. This represents a 5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Acadia Healthcar's revenue growing?

Acadia Healthcar (ACHC) revenue grew by 5.0% year-over-year, from $3.2B to $3.3B in fiscal year 2025.

Is Acadia Healthcar profitable?

No, Acadia Healthcar (ACHC) reported a net income of -$1.1B in fiscal year 2025, with a net profit margin of -33.3%.

How much debt does Acadia Healthcar have?

As of fiscal year 2025, Acadia Healthcar (ACHC) had $133.2M in cash and equivalents against $2.5B in long-term debt.

What is Acadia Healthcar's net profit margin?

Acadia Healthcar (ACHC) had a net profit margin of -33.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Acadia Healthcar's return on equity (ROE)?

Acadia Healthcar (ACHC) has a return on equity of -56.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Acadia Healthcar's free cash flow?

Acadia Healthcar (ACHC) recorded an outflow of $439.9M in free cash flow during fiscal year 2025. This represents a 21.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Acadia Healthcar's operating cash flow?

Acadia Healthcar (ACHC) generated $131.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Acadia Healthcar's total assets?

Acadia Healthcar (ACHC) had $5.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Acadia Healthcar's capital expenditures?

Acadia Healthcar (ACHC) invested $571.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Acadia Healthcar buy back shares?

Yes, Acadia Healthcar (ACHC) spent $50.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Acadia Healthcar have outstanding?

Acadia Healthcar (ACHC) had 92M shares outstanding as of fiscal year 2025.

What is Acadia Healthcar's current ratio?

Acadia Healthcar (ACHC) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.

What is Acadia Healthcar's debt-to-equity ratio?

Acadia Healthcar (ACHC) had a debt-to-equity ratio of 1.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Acadia Healthcar's return on assets (ROA)?

Acadia Healthcar (ACHC) had a return on assets of -20.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Acadia Healthcar's Piotroski F-Score?

Acadia Healthcar (ACHC) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Acadia Healthcar's earnings high quality?

Acadia Healthcar (ACHC) reported a net loss of $1.1B while generating $131.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Acadia Healthcar?

Acadia Healthcar (ACHC) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.